Live Breaking Biotech News and Articles

Biotech News Journal

Subscribe to Biotech News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Biotech News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

Top Stories

DALLAS, Aug. 21, 2014 /PRNewswire-iReach/ -- Amid the proliferation of real time data from sources such as mobile devices, web, social media, sensors, log files and transactional applications, Big Data has found a host of vertical market applications, ranging from fraud detection to R&D. Photo - "Big Data Market: 2014 – 2020 – Opportunities, Challenges, Strategies, Industry Verticals & Forecasts" Key Findings: In 2014 Big Data vendors will pocket nearly $30 Billion from hardware, software and professional services revenues Big Data investments are further expected to grow at a CAGR of nearly 17% over the next 6 years, eventually accounting for $76 Billion by the end of 2020 The market is ripe for acquisitions of pure-play Big Data startups, as competition heats up between IT incumbents Nearly every large scale IT ven... (more)

Microbia Selects ChemOne to Support Aggressive Start-up Growth of Company

Enterprise Resource Planning (ERP) solution. ChemOne will provide the foundation for operational efficiency for Microbia's manufacturing and business requirements to prepare them for the launch of their line of naturally derived carotenoids for the food ingredient and nutritional supplement markets. ChemOne is a certified SAP® Business All-in-One solution that is specifically designed for Small to Medium Enterprises (SMEs) in the chemical industry. It accelerates an organization's return on investment by providing fully optimized operational systems to support rapid growth with minimal risk of disruption to the business. "YASH is excited to partner with Microbia on their ERP initiative," comments Kevin Jansen, Executive Vice President of YASH Technologies. "With their aggressive plans for growth, ChemOne will provide the system optimization needed to sustain this ... (more)

iland Internet Solutions and Vizioncore to Offer Virtualization Solutions

iland Internet Solutions and Vizioncore have announced they have entered into a partnership to leverage each company’s products and services to provide complete virtualization solutions for the small and medium-sized enterprise markets. Vizioncore’s vReplicator, a solution designed specifically for virtualization, will be deployed in iland’s virtual data centers, providing ‘best in class’ replication solutions for iland, iland’s customers and for external clients’ on-premise use. Vizioncore leverages iland’s Hosted VMware platform to enable new technology adopters to achieve high-availability services more cost-effectively. iland’s Virtual Data Centers, located in Los Angeles, Houston, Dallas, Boston and the Washington DC area, provide access to iland’s enterprise Hosted VMware Cloud Services, where businesses can host multiple operating systems and applications lo... (more)

Swine Flu Stocks are Seeing Their Largest Pullback Yet

Weekly Digest announced the publication of a special report on investment opportunities in the connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for Gilead Sciences, Sinovac Biotech, Dynavax Technologies, Hemispherx BioPharma (Amex: HEB), BioCryst Pharmaceuticals and several others. After posting large gains throughout 2009, swine flu stocks are seeing their largest pullback yet. For investors looking to position their portfolios for flu season, there are more ways to trade the flu than ever. Investors have large-cap pharmaceutical plays to choose from, and some of the more volatile, small-cap names have proven the efficacy of their drugs, while others are too far behind in their clinical trials to capitalize on the current pandemic. The report covers these topics and more recent reports: -- Which small-cap swine flu plays have a real chance o... (more)

Avere Systems Solves VMware Storage Problem at Clinical Stage Biotechnology Company

FXT Series Edge filers improves 'bursty' VM traffic flow at Concert Pharmaceuticals PITTSBURGH, August 20, 2012 - Avere Systems today announced that Concert Pharmaceuticals Inc., a clinical stage biotechnology company, has implemented its FXT Series Edge filers into its existing storage infrastructure. The Avere Edge filers were chosen to reduce latency and improve performance of applications critical in Concert's mission. Lexington, Mass.-based Concert is dedicated to creating new medicines through its proprietary DCE Platform™ that utilizes the naturally occurring element deuterium - a safe and stable form of the element hydrogen. Concert uses deuterium to improve upon the metabolic properties of a drug while making little or no change to its intrinsic effectiveness. Concert has executed on this approach with its lead program, CTP-499, in Phase 2 clinical testing ... (more)

Hadoop & Big Data Market [Hardware, Software, Services, Hadoop-as-a-Service] - Trends, Geographical Analysis & Worldwide Market Forecasts (2012 - 2017)

NEW YORK, Oct. 24, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue: Hadoop & Big Data Market [Hardware, Software, Services, Hadoop-as-a-Service] - Trends, Geographical Analysis & Worldwide Market Forecasts (2012 – 2017)[Hardware-Software-Services-Hadoop-as-a-Service]---Trends-Geographical-Analysis--Worldwide-Market-Forecasts-2012-–-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Software Big Data has grown in significance over the last few years because of the pervasiveness of its application, across areas ranging from weather forecasting to analyzing business trends, fighting crime and preventing epidemics etc. Big data sets are so large that traditional data management tools are incapable of analyzing all the data effectively and processi... (more)

Mimecast Ranked In Fourth Consecutive Annual Deloitte UK Fast 50

Revenue grown 526 per cent over five years London, UK - 14th November 2013 - Mimecast has been included for the fourth consecutive year in the 2013 Deloitte Technology Fast 50, a ranking of the 50 fastest-growing technology companies in the UK. Mimecast is one of only two firms to have appeared in each Technology Fast 50 ranking since 2010. The ranking is based on percentage revenue growth over five years and Mimecast grew by 526 per cent, achieving 45th place in the 2013 ranking. Peter Bauer, CEO and co-founder, Mimecast said, "We are delighted to make the Technology Fast 50 for UK technology firms again this year. To be ranked once is great recognition of the progress we are making as a firm but we stand out for making the list four years in a row. This shows we are leading the pack in our sustained performance in the UK tech sector. It also reflects our commitmen... (more)

Rider Revenge App Launches on Apple Store, Aims to Stop Distracted Driving

Madison, NJ, June 16, 2014 --( Rider Revenge, the technology platform to reduce Distracted Driving, has announced the launch of their app’s prototype on Apple’s App Store. The launch comes on the heels of successfully closing the Company’s first round of crowd-funding. "The launch of our prototype on the Apple Store is a significant development milestone for our company," said Peter Gallagher, Founder & CEO of Rider Revenge. "During the last two months, we have gained tremendous momentum. We closed our round of funding on Kiva Zip with nearly 200 lenders. Then we finished development of our beta prototype of the app. User feedback is helping us to shape and progress the app toward a full commercial product later this year." The app is built on the company’s geo-specific, time-dependent mapping technology, called Crowd Spotting. The software collects the input... (more)

Examine the World Biocompatible Materials Market

LONDON, UNITED KINGDOM -- (MARKET WIRE) -- 07/07/08 -- announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Biocompatible Materials Market This report analyzes the worldwide markets for Biocompatible Materials in Millions of US$. The specific product segments analyzed are Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the North America, Japan, Europe, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2015. The report profiles 70 companies including many key and niche players worldwide such as A.P. Pharma, Inc., AST Products, Inc., Angiotech... (more) Specialized Software Systems for the Medical Device Industry Named by LifeScience Alley(R) As Preferred Provider

Minnesota-based Trade Association Cites e-Zassi Value for Members Developing, Commercializing Medical Device Technologies FERNANDINA BEACH, Fla., June 18 /PRNewswire/ -- software systems designed specifically for networking and decision support for medical devices, has been named a preferred provider for LifeScience Alley(R), a Minnesota-based trade association serving over 600 member organizations that represent all sectors of the life sciences. The partnership will provide for education, discounted subscription rates and co-marketing around's proprietary software systems. Created by and for medical device industry professionals, is the industry's first subscription-based online network and decision support software platform to improve decision-making and increase the speed and ability for successful networking for small, m... (more)

ISI Unveils Prestigious Speaker Line-Up for eSolutions Conference in Barcelona

Image Solutions Inc. (ISI), a leading provider of electronic submissions management and publishing solutions for the life sciences industry, has unveiled a prestigious line-up of speakers for its annual eSolutions Conference in Barcelona, Spain, this September to support an agenda aimed at reinventing the regulatory function. The ISI eSolutions Conference, now in its seventh year, takes place on 29-30 September, at the Spanish city’s Hotel Arts, following the theme, “Accelerating Change in the New R&D Paradigm”. The annual event is one of the most recognised dates in the calendar for senior-level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how they are addressing some of their most pressing challenges. Those attending in Barcelona this September can look forward to an in... (more)